GrantsFeed
Grants & Funding

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Grant· National Institutes of Health· US· updated 2026-07-17
Deadline
Closes 2028-01-07
View & apply on official source

The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice. Specifically, the focus of this FOA is on the identification and initial biological, analytical and clinical evaluation of biomarkers and biomarker signatures for neurological and neuromuscular disorders. Although research supported by this FOA can include animal studies, it must also include preliminary human evaluation using carefully standardized human samples or datasets. The goal of this initiative is to deliver candidate biomarkers or biomarker signatures that are ready for definitive analytical and clinical validation studies.

Don't miss the next one like this

New health grants in US open all the time. Get a free weekly email with only the ones that match — nothing else.

Get matching Health grants by email →
Weekly digest of only what matches your filters. Unsubscribe anytime.

Want help winning this?

Enter your email and we'll send the official application link, deadlines and pointers right away — free. Want a hand? Tick the box and we'll introduce you to a vetted grant or bid writer. The intro's free, and you only pay if you choose to work with them.

Eligibility
Open to nonprofit organizations. Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Related opportunities

See all alternatives →

More grantsHealth · US

People also viewed

Other grants visitors looked at from National Institutes of Health.

Always confirm details on the official source before applying — see our methodology.

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) · GrantsFeed